MEN1 and Angiofibroma: We propose a predictive weighted risk score to further refine the clinical criterion by inclusion of additional characteristics: age of first primary MEN1-related manifestation ≤ 39, presence of recurrent PHPT or multigland parathyroid disease, presence of dpNETs, and presence of angiofibromas or collagenomas.